Published on 20 Mar 2023 on Zacks via Yahoo Finance
Here's Why You Should Retain Boston Scientific (BSX) Now
Boston Scientific Corporation BSX is well poised for growth in coming quarters, backed by impressive value-added acquisitions. New strategic investments to drive electrophysiology are boosting investors’ optimism. However, unfavorable currency movements and stiff competition are a concern.
In the past year, this Zacks Rank #3 (Hold) stock has gained 8.2% against a 41.4% fall of the industry and an 13.3% decline of the S&P 500.
The renowned manufacturer of medical devices and products has a market capitalization of $69.3 billion. The company’s long-term projected growth of 11.2% compares with the industry’s growth projection of 14.6%.